Advertisement
Home »

Time to onset of cardiovascular and cerebrovascular outcomes after hypertensive disorders of pregnancy: a nationwide, population-based retrospective cohort study.

Mar 20, 2023

ABOUT THE EXPERTS

  • Emmanuel Simon

    Gynecology, Obstetrics, and Fetal Medicine, University Hospital, Dijon, France.

    Sonia Bechraoui-Quantin S

    Gynecology, Obstetrics, and Fetal Medicine, University Hospital, Dijon, France; Biostatistics and Bioinformatics (DIM), University Hospital, Dijon, France.

    Solène Tapia

    Biostatistics and Bioinformatics (DIM), University Hospital, Dijon, France.

    Jonathan Cottenet

    Biostatistics and Bioinformatics (DIM), University Hospital, Dijon, France.

    Anne-Sophie Mariet

    Biostatistics and Bioinformatics (DIM), University Hospital, Dijon, France; Inserm, CIC 1432, Dijon, France; Dijon University Hospital, Clinical Investigation Center, clinical epidemiology/ clinical trials unit, Dijon, France.

    Yves Cottin

    Cardiology Department. University Hospital of Dijon, France; Pathophysiology and Epidemiology of Cerebro-CardioVascular Diseases. University of Burgundy, Dijon, France; Registre des Infarctus du Myocarde de Côte d’Or, University Hospital of Dijon, France.

    Maurice Giroud

    Neurology Department, University Hospital of Dijon, France; Dijon Stroke Registry (Santé Publique France – Inserm) – EA 7460 (Pathophysiology and Epidemiology of Cerebro-CardioVascular Diseases). University of Burgundy. UFBC, Dijon, France.

    Jean-Christophe Eicher

    Cardiology Department. University Hospital of Dijon, France.

    Basky Thilaganathan

    Fetal Medicine Unit, St George’s University Hospitals NHS Foundation Trust, London, UK.

    Catherine Quantin

    Biostatistics and Bioinformatics (DIM), University Hospital, Dijon, France; Inserm, CIC 1432, Dijon, France; Dijon University Hospital, Clinical Investigation Center, clinical epidemiology/ clinical trials unit, Dijon, France; Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, High-Dimensional Biostatistics for Drug Safety and Genomics, CESP, Villejuif, France. Electronic address: catherine.quantin@chu-dijon.fr.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement